What is Calcitonin Gene-Related peptide – CGRP? Part 2
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Migraine.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
Merck. “Insights into the pathophysiology of migraine.” Migraine Resources. Copyright © 2009–2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. • Durham, Paul, PhD. and A. Russo (2003). “Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons“. J Neurosci 23 (3): 807–815. PMID 12574409 • Durham, Paul, PhD. (2006). “Calcitonin Gene-Related Peptide (CGRP) and Migraine”. Headache. 46 (1): S3–S8. PMCID: PMC3134175 • Durham, Paul, PhD., Cady, Roger, MD and R. Cady (2004). “Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy“. Headache 44 (1): 35–42. doi:10.1111/j.1526-4610.2004.04007.x. PMID 14979881